Clin2
NCT07123467Possibly a fitRecruiting

Study on CBD and learning for generalized anxiety

Generalized Anxiety Disorder (GAD)Anxiety Disorders

Part of Mental health clinical trials.

This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
90 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • Right-handed
  • Aged 18 to 45 years
  • Diagnosed with generalized anxiety disorder or high anxiety scores
  • In good general health with no major medical or brain conditions
  • No use of cannabis or CBD products in the past month
  • No current or recent psychotherapy or anxiety medications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07764211Not yet recruiting
A study of generalized anxiety disorder to learn more about it

This study aims to better understand generalized anxiety disorder by following a group of people over time. You won't receive a new treatment, but you will help researchers learn more about the condition, which may lead to better care in the future.

Shanghai
NCT06969170Recruiting· Phase 2
Psilocybin oral solution for generalized anxiety disorder trial

This study tests a psilocybin oral solution in adults with generalized anxiety disorder (GAD). It aims to see if the drug is safe, tolerable, and helpful for reducing anxiety symptoms.

Kingston, Ontario
NCT06775145Not yet recruiting
Using brain stimulation to treat anxiety disorders

This trial tests a non-invasive brain stimulation technique called high-definition transcranial electrical stimulation (HD-tES) to see if it can help people with Generalized Anxiety Disorder (GAD). If you have GAD and have been stable on your current treatment, this study may be a good fit for you.

NCT05283382Recruiting· Early Phase 1
Cannabidiol trial for learning and anxiety

This early-phase study tests how cannabidiol (CBD) affects learning and anxiety. You may be able to join if you meet age and health requirements and have not used CBD or other cannabis recently.

Storrs, Connecticut
NCT07767903Recruiting· Phase 3
Study of a new medicine for generalized anxiety disorder

This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.

Cherry Hill, New Jersey
NCT05649059Recruiting· Phase 4
Cannabidiol study for social anxiety symptoms

This trial studies whether cannabidiol (CBD) helps improve social anxiety symptoms. You may be able to join if you are an adult with significant social anxiety and meet medication and health safety requirements.

Cambridge, Massachusetts

Hear when a new Anxiety Disorders trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.